PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
98 hedge funds and large institutions have $146M invested in Aratana Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
93% less call options, than puts
Call options by funds: $310K | Put options by funds: $4.5M
Holders
98
Holding in Top 10
1
Calls
$310K
Puts
$4.5M
Top Buyers
| 1 | +$14M | |
| 2 | +$2.95M | |
| 3 | +$1.25M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.08M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$795K |
Top Sellers
| 1 | -$2.94M | |
| 2 | -$1.78M | |
| 3 | -$1.16M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.12M |
| 5 |
Jennison Associates
New York
|
-$909K |